These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29867433)

  • 1. Everolimus Reduces the Size of Tuberous Sclerosis Complex-Related Huge Renal Angiomyolipomas Exceeding 20 cm in the Longest Diameter.
    Toriu N; Mizuno H; Sawa N; Sumida K; Suwabe T; Hayami N; Sekine A; Yamanouchi M; Hoshino J; Takaichi K; Yanagita M; Fujimaru T; Mori T; Sohara E; Uchida S; Ubara Y
    Case Rep Oncol; 2018; 11(2):258-267. PubMed ID: 29867433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial.
    Cai Y; Guo H; Wang W; Li H; Sun H; Shi B; Zhang Y
    Orphanet J Rare Dis; 2018 Mar; 13(1):43. PubMed ID: 29587809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal angiomyolipoma and tuberous sclerosis complex: long-term safety and efficacy outcomes of Everolimus therapy.
    Ruiz Guerrero E; Ledo Cepero MJ; Ojeda Claro AV; Soto Delgado M; Álvarez-Ossorio Fernández JL
    Actas Urol Esp (Engl Ed); 2021 May; 45(4):264-272. PubMed ID: 33637375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study.
    Bissler JJ; Kingswood JC; Radzikowska E; Zonnenberg BA; Belousova E; Frost MD; Sauter M; Brakemeier S; de Vries PJ; Berkowitz N; Voi M; Peyrard S; Budde K
    PLoS One; 2017; 12(8):e0180939. PubMed ID: 28792952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT characteristics predict the response to everolimus or sirolimus of renal angiomyolipomas in patients with tuberous sclerosis complex.
    Wang W; Guo H; Shi B; Sun H; Li H; Zhang Y; Cai Y
    Int Urol Nephrol; 2019 Apr; 51(4):671-676. PubMed ID: 30756282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent everolimus administration for renal angiomyolipoma associated with tuberous sclerosis complex.
    Hatano T; Inaba H; Endo K; Egawa S
    Int J Urol; 2017 Nov; 24(11):780-785. PubMed ID: 28905429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II Trial.
    Geynisman DM; Kadow BT; Shuch BM; Boorjian SA; Matin SF; Rampersaud E; Milestone BN; Plimack ER; Zibelman MR; Kutikov A; Smaldone MC; Chen DY; Viterbo R; Joshi S; Greenberg RE; Malizzia L; McGowan T; Ross EA; Uzzo RG
    J Urol; 2020 Sep; 204(3):531-537. PubMed ID: 32250730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function, complications, and outcomes of a reduction in tumor size after transarterial embolization for renal angiomyolipomas: a meta-analysis.
    Lin L; Li X; Guan H; Wang J; Tong X; Yang M; Zou Y
    J Int Med Res; 2019 Apr; 47(4):1417-1428. PubMed ID: 30898061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex: A single institution experience in Japan.
    Hatano T; Chikaraishi K; Inaba H; Endo K; Egawa S
    Int J Urol; 2016 Oct; 23(10):833-838. PubMed ID: 27480662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Everolimus in Preoperative Neoadjuvant Therapy of Tuberous Sclerosis Complex Associated With Renal Angiomyolipoma: A Single-Center Report of 5 Cases.
    Guo G; Gu L; Zhang X
    Clin Genitourin Cancer; 2019 Dec; 17(6):e1099-e1103. PubMed ID: 31601513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal lesion growth in children with tuberous sclerosis complex.
    Ewalt DH; Sheffield E; Sparagana SP; Delgado MR; Roach ES
    J Urol; 1998 Jul; 160(1):141-5. PubMed ID: 9628635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of renal angiomyolipomas in patients with tuberous sclerosis.
    van Baal JG; Smits NJ; Keeman JN; Lindhout D; Verhoef S
    J Urol; 1994 Jul; 152(1):35-8. PubMed ID: 8201681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of everolimus treatment for regrown renal angiomyolipoma associated with tuberous sclerosis complex after transcatheter arterial embolization.
    Hatano T; Matsu-Ura T; Mori KI; Inaba H; Endo K; Tamari M; Egawa S
    Int J Clin Oncol; 2018 Dec; 23(6):1134-1139. PubMed ID: 30069798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of everolimus on tuberous sclerosis complex-associated renal angiomyolipoma: A preliminary report.
    Tsai JD; Wei CC; Yang SH; Fan HC; Hsu CC; Tung MC; Tsai ML; Sheu JN
    Nephrology (Carlton); 2017 Dec; 22(12):1017-1022. PubMed ID: 27565896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the Tuberous Sclerosis Renal Guidelines from the 2012 Consensus Conference: Current Data and Future Study.
    Kingswood JC; Bissler JJ; Budde K; Hulbert J; Guay-Woodford L; Sampson JR; Sauter M; Cox J; Patel U; Elmslie F; Anderson C; Zonnenberg BA
    Nephron; 2016; 134(2):51-58. PubMed ID: 27504842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical analysis of tuberous sclerosis complex complicated with renal angiomyolipoma: a report of 22 cases].
    Ting WY; Zhang YS; Li HZ; Zhang XB; Xu WF
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(26):2056-8. PubMed ID: 24169285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis.
    Bissler JJ; Nonomura N; Budde K; Zonnenberg BA; Fischereder M; Voi M; Louveau AL; Herbst F; Bebin EM; Curatolo P; Zonta A; Belousova E
    PLoS One; 2018; 13(9):e0201005. PubMed ID: 30192751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management of tuberous sclerosis complex with big fat-poor bilateral renal angiomyolipomas: A case report.
    Zhang L; Zeng J; Yao Z
    Int J Surg Case Rep; 2023 Dec; 113():109060. PubMed ID: 37979555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.
    Bissler JJ; Kingswood JC; Radzikowska E; Zonnenberg BA; Frost M; Belousova E; Sauter M; Nonomura N; Brakemeier S; de Vries PJ; Berkowitz N; Miao S; Segal S; Peyrard S; Budde K
    Nephrol Dial Transplant; 2016 Jan; 31(1):111-9. PubMed ID: 26156073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Renal Angiomyolipomas in Tuberous Sclerosis Complex: A Case Report and Literature Review.
    Hunter-Dickson M; Wu P; Athavale A; Wang AY
    J Clin Med; 2022 Oct; 11(20):. PubMed ID: 36294405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.